TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Polar Biomedicals AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
29,724
|
27,123
|
22,917 |
| Financial expenses |
303
|
467
|
278 |
| Earnings before taxes |
4,833
|
2,140
|
1,236 |
| Total assets |
17,164
|
13,630
|
12,280 |
| Current assets |
17,103
|
13,603
|
12,275 |
| Current liabilities |
6,254
|
5,705
|
4,675 |
| Equity capital |
10,910
|
7,925
|
7,605 |
| - share capital |
410
|
410
|
410 |
| Employees (average) | 2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.6%
|
58.1%
|
61.9% |
| Turnover per employee | 11,458 | ||
| Profit as a percentage of turnover |
16.3%
|
7.9%
|
5.4% |
| Return on assets (ROA) |
29.9%
|
19.1%
|
12.3% |
| Current ratio |
273.5%
|
238.4%
|
262.6% |
| Return on equity (ROE) |
44.3%
|
27.0%
|
16.3% |
| Change turnover |
2,601
|
4,206
|
-2,059 |
| Change turnover % |
10%
|
18%
|
-8% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.